DocSym
β
Searchsearch
Search
(F12) Mental and behavioural disorders due to use of cannabinoids
More details coming soon
309 218 in individuals diagnosis mental and behavioural disorders due to use of cannabinoids confirmed
1 830 deaths with diagnosis mental and behavioural disorders due to use of cannabinoids
1% mortality rate associated with the disease mental and behavioural disorders due to use of cannabinoids
Diagnosis mental and behavioural disorders due to use of cannabinoids is diagnosed Men are 63.84% more likely than Women
253 307
Men receive the diagnosis mental and behavioural disorders due to use of cannabinoids
1 830 (0.7 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
55 911
Women receive the diagnosis mental and behavioural disorders due to use of cannabinoids
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease mental and behavioural disorders due to use of cannabinoids - Men and Women aged 15-19
In Men diagnosis is most often set at age 10-84
Less common in men the disease occurs at Age 0-9, 85-95+Less common in women the disease occurs at Age 0-9, 70-74, 80-95+
In Women diagnosis is most often set at age 10-69, 75-79
Disease Features mental and behavioural disorders due to use of cannabinoids
Absence or low individual and public risk
Mental and behavioural disorders due to use of cannabinoids - what does this mean
Mental and behavioural disorders due to use of cannabinoids are caused by the disruption of the endocannabinoid system in the brain. this disruption can lead to changes in mood, memory, cognition, and behaviour, as well as increased anxiety, paranoia, and psychosis. long-term use of cannabinoids can also result in addiction and withdrawal symptoms.
What happens during the disease - mental and behavioural disorders due to use of cannabinoids
The pathogenesis of mental and behavioural disorders due to the use of cannabinoids is complex and not fully understood. it is believed that cannabinoids can affect the brain’s reward and pleasure pathways, resulting in changes in mood, motivation, and cognition. additionally, cannabinoids can alter the production of neurotransmitters such as serotonin, dopamine, and glutamate, which can lead to changes in behaviour, including paranoia, anxiety, and depression. long-term use of cannabinoids can also lead to an increased risk of addiction and other mental health issues.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Psychological evaluation
- Laboratory tests
- Brain imaging (MRI or CT scan)
- Neuropsychological testing
- Drug screening
- Genetic testing
- Urine and blood tests
- Family history
- Substance use history
Treatment and Medical Assistance
Main goal: Treat mental and behavioural disorders due to use of cannabinoids.
- Psychotherapy
- Cognitive-behavioural therapy
- Group therapy
- Family therapy
- Medication management
- Substance use disorder treatment
- Support groups
- Self-help strategies
- Education and prevention programs
- Crisis intervention
37 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Mental and behavioural disorders due to use of cannabinoids - Prevention
The best way to prevent mental and behavioural disorders due to use of cannabinoids is to abstain from using them altogether. if use is necessary, it should be done in moderation and under the supervision of a qualified medical professional. education on the potential risks associated with using cannabinoids is also important in order to help people make informed decisions.